Resources

Type of publications
Regions
Diseases

5192 results found

2023 ∙ Xu, S. Li, J. Wang, H. Wang, F. Yin, Z. Wang, Z.

Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2023 ∙ Beran, A. Mhanna, A. Mhanna, M. Hassouneh, R. Abuhelwa, Z. Mohamed, M. F. H. Sayeh, W. Musallam, R. Assaly, R. Abdeljawad, K.

Real-world effectiveness of COVID-19 vaccination in liver cirrhosis: a systematic review with meta-analysis of 51,834 patients

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Xu, M. Liu, C. Du, Z. Bai, Y. Wang, Z. Gao, C.

Real-world effectiveness of monkeypox vaccines: A systematic review

  • Adults
  • Mpox
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Palalay, H. Vyas, R. Tafuto, B.

Real-world effectiveness of mRNA COVID-19 vaccines in the elderly during the Delta and Omicron variants: Systematic review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Sarwar, M. U. Waasia, F. Z. Aloqbi, A. A. Alandiyjany, M. Alqahtani, R. M. Hafiz, L. A. Shamlan, G. Albreiki, M.

Real-world effectiveness of the inactivated COVID-19 vaccines against variant of concerns: meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Xu, W. Ren, W. Wu, T. Wang, Q. Luo, M. Yi, Y. Li, J.

Real-World Safety of COVID-19 mRNA Vaccines: A Systematic Review and Meta-Analysis

  • All age groups
  • Healthcare workers
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Shearn, C. Krockow, E. M.

Reasons for COVID-19 vaccine hesitancy in ethnic minority groups: A systematic review and thematic synthesis of initial attitudes in qualitative research

  • All age groups
  • COVID-19
  • Acceptance
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Cardoso Pinto, A. M. Shariq, S. Ranasinghe, L. Sundar Budhathoki, S. Skirrow, H. Whittaker, E. Seddon, J. A.

Reasons for reductions in routine childhood immunisation uptake during the COVID-19 pandemic in low- and middle-income countries: A systematic review

  • Newborn
  • Children
  • Healthcare workers
  • Parents/caregivers
  • Low and Middle Income Countries
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Arya, S. Norton, N. Kaushik, P. Brandtmuller, A. Tsoumani, E.

Recent changes to adult national immunization programs for pneumococcal vaccination in Europe and how they impact coverage: A systematic review of published and grey literature

  • Europe
  • Adults
  • Older adults
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Goon, P. Sauzet, O. Schuermann, M. Oppel, F. Shao, S. Y. Scholtz, L. U. Sudhoff, H. Goerner, M.

Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy

  • Adults
  • Older adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...